Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The state of the art of PROTAC technologies for drug discovery
HTML
Details
Locations
Year:
2022
Type:
review
Source:
European Journal of Medicinal Chemistry
DOI:
10.1016/j.ejmech.2022.114290
Authors:
Chao Wang,
Cangxin Zheng,
Han Wang,
Liangren Zhang,
Zhenming Liu,
Ping Xu
show all 6
Institutions:
Peking University,
State Key Laboratory of Natural and Biomimetic Drugs
Language:
English
Topic:
Protein Degradation and Inhibitors
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
PROTACs,
targeted protein degradation,
degraders,
misfolded protein degradation,
RNA degradation,
drug discovery,
cancer therapy,
neurodegenerative diseases,
antiviral agents
show all 9
SDG:
Good health and well-being
Open Access status:
closed
Funders:
National Natural Science Foundation of China,
Peking University,
National University's Basic Research Foundation of China,
Fundamental Research Funds for the Central Universities,
Interdisciplinary Medicine Seed Fund of Peking University
Awards:
G6937340764,
G8146084917
OpenAlex ID:
W4220906618
FWCI:
2.731
Cites:
73
Cited by:
138
Related to:
10